Anticoagulant Treatments and Percutaneous Coronary Angioplasty
Status:
Terminated
Trial end date:
2013-08-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether adjunction of intravenous anticoagulant
therapy (enoxaparin, HNF, bivalirudin) to antiaggregation with clopidogrel and aspirin
improves in-hospital results of percutaneous transluminal coronary angioplasty (ptca) in
selected patients.